
Arena Pharmaceuticals ARNA
Annual report 2021
added 12-16-2023
Arena Pharmaceuticals DIO Ratio 2011-2026 | ARNA
Annual DIO Ratio Arena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 160 | 263 | 510 | 754 | 602 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 754 | 160 | 458 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 21.41 | 0.21 % | $ 1 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Akebia Therapeutics
AKBA
|
147 | $ 1.53 | 4.08 % | $ 393 M | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.15 | -0.95 % | $ 444 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 25.2 | 4.48 % | $ 3.21 B | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.5 | 2.04 % | $ 399 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.56 | 2.39 % | $ 6.83 B |